| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.1M | +63.8% |
| SG&A Expense | $12.6M | +11.5% |
| Operating Income | -$27.7M | -34.9% |
| Pre-tax Income | -$27.0M | -30.8% |
| Income Tax | $0 | — |
| Net Income | -$27.0M | -30.8% |
| EPS (Basic) | -$0.21 | -16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.9M | -18.7% |
| Current Assets | $118.2M | -16.3% |
| Total Assets | $123.5M | -12.6% |
| Current Liabilities | $5.6M | +78.1% |
| Total Liabilities | $5.6M | +78.1% |
| Stockholders' Equity | $118.0M | -14.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | -26.0% |
| Capital Expenditures | $27K | +200.0% |
| Investing Cash Flow | -$4.7M | — |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$20.8M | -26.1% |